Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 15, 2022 - Issue
Submit an article Journal homepage
390
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Efficacy and Safety of Empagliflozin in Patients with Type 2 Diabetes Mellitus Fasting During Ramadan: A Real-World Study from Bangladesh

MD Faruque Pathan1 BIRDEM General Hospital, Dhaka, BangladeshCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9163-2473
ORCID Icon,
Nazma Akter2 MARKS Medical College & Hospital, Dhaka, Bangladesh
,
Shahjada Selim3 Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
,
M Saifuddin4 Dhaka Medical College, Dhaka, Bangladesh
,
Nazmul Kabir Qureshi5 National Healthcare Network, Dhaka, BangladeshORCID Iconhttps://orcid.org/0000-0003-4327-8056
ORCID Icon,
ABM Kamrul-Hasan6 Mymensingh Medical College & Hospital, Mymensingh, BangladeshORCID Iconhttps://orcid.org/0000-0002-5681-6522
ORCID Icon,
Mohammad Abdul Hannan7 North East Medical College & Hospital, Sylhet, Bangladesh
,
Md Ashraf Uddin Ahmed1 BIRDEM General Hospital, Dhaka, Bangladesh
,
Marufa Mustari3 Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshORCID Iconhttps://orcid.org/0000-0002-8519-4988
ORCID Icon &
Ashish Kumar Chakraborty1 BIRDEM General Hospital, Dhaka, Bangladesh
 show all
Pages 4011-4021 | Received 04 Aug 2022, Accepted 15 Nov 2022, Published online: 22 Dec 2022

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Xu Jiang, Sungyeun Bae, Deok Yong Yoon, Shin Jung Park, Jaeseong Oh, Joo-Youn Cho & Kyung-Sang Yu. (2023) Comparison of the Pharmacokinetics, Safety, and Tolerability of Two Empagliflozin Formulations in Healthy Korean Subjects. Drug Design, Development and Therapy 17, pages 2137-2145.
Read now

Articles from other publishers (2)

Mayada M. Samkari, Neda'a S. Bokhari, Raghad Alhajaji, Malaz E. Ahmed, Ahmad Al Raddadi, Alaa K. Bahget, Sarah F. Saleh, Faisal Aljehani, Saud H. Alzahrani, Sarah S. Alsifyani, May M. Samkari, Aisha F. Badr, Mai Alalawi & Khalid Al Sulaiman. (2023) Safety and tolerability of Empagliflozin use during the holy month of Ramadan by fasting patients with type 2 diabetes: A prospective cohort study. Saudi Pharmaceutical Journal 31:6, pages 972-978.
Crossref
Khadija Hafidh, Tawfik A. Besheya, Rafik Elmehdawi & Salem A. Beshyah. (2023) Ramadan Fasting and Diabetes (2022): The Year in Review. Journal of Diabetes and Endocrine Practice.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.